arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

BioCardia, Inc.

BCDA

$0.98 ▲ +0.02 (+2.27%) at close

17 Visible periods

25 Metrics

Absolute Benchmarks

Price Chart

Health

Weak

Bearish Absolute basis

auto_awesome

Analytical Summary

On an absolute basis, BioCardia, Inc. shows weak fundamentals, weighed down by Return on Invested Capital and FCF / Net Income. These readings use fixed quality thresholds rather than peer benchmarks, because too few comparable companies are available to rank against.

Market Cap $6.5M

Dividend Yield —

Revenue Growth N/M

Op. Margin —

ROIC -730.7% ↗

FCF / Share $-1.12 ↗

Trailing P/E —

Price / Book 11.8x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

17-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$0.00

↓ -100.0% —

Net Income Profit after all expenses

$-8.23M

↓ -3.5% —

FCF / Share Free cash flow per share

$-1.12

↑ +61.2% —

info Signals below are graded against fixed quality thresholds, not peers — peer ranking needs more comparable companies.

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Invested CapitalReturn on Invested Capital of -730.7% is weak on an absolute basis (target > 10%)
FCF / Net IncomeFCF / Net Income of 0.90x is caution on an absolute basis (target > 1x)

Health Breakdown

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗
Revenue Growth YoY (%)	N/M	-87.8% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1198%)	-64.7% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-909%)	33.2% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+315%)	600.0% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+7400%)	-79.6% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1095%)	13.6% Good ↑ Good Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+70%)	30.5% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+281%)	-16.8% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-311%)	-36.3% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-554%)	—	—	—	—	—	—	—
EPS Growth YoY (%)	57.6% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-427.3% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	17.9% Good Good Year-over-year change in earnings per share Optimal: > 10%	10.7% Fair Fair Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-3.5% Weak ↓ Weak Declining Year-over-year change in net income	31.3% Excellent ↑ Excellent Improving Year-over-year change in net income	2.8% Caution ↓ Caution Declining Year-over-year change in net income	5.7% Fair ↑ Fair Improving Year-over-year change in net income	15.9% Good ↑ Good Improving Year-over-year change in net income	-2.0% Weak ↑ Weak Improving Year-over-year change in net income	-5.2% Weak ↑ Weak Improving Year-over-year change in net income	-13.6% Weak ↑ Weak Improving Year-over-year change in net income	-19.4% Weak ↓ Weak Declining Year-over-year change in net income	-53.9% Weak ↓ Weak Declining Year-over-year change in net income	N/M	1131.6% Excellent ↑ Excellent Improving Year-over-year change in net income	-93.8% Weak Weak Year-over-year change in net income	-96.8% Weak Weak Year-over-year change in net income	N/M	—	—
FCF Growth YoY (%)	61.2% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	-510.0% Weak ↓ Weak Declining Year-over-year change in free cash flow	21.4% Good Good Year-over-year change in free cash flow	3.2% Caution Caution Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	—	-61.5% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	48.7% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	23.9% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	17.5% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	-32.9% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	7.2% Fair Fair Compound annual revenue growth over 3 years	-11.6% Weak Weak Compound annual revenue growth over 3 years	—	—	—	—	—	—	—	—	—
Revenue CAGR 5Y (%)	—	-39.4% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	-5.3% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	23.1% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	12.0% Good Good Compound annual revenue growth over 5 years	-30.7% Weak Weak Compound annual revenue growth over 5 years	—	—	—	116.9% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—	—

💰 Are margins durable? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗
Effective Tax Rate (%) (%)	—	—	—	—	—	—	—	—	—	—	—	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—
FCF / Net Income (x)	0.90x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.99x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.86x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.89x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.83x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.83x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.65x Weak → Weak Stable Free cash flow relative to reported net income Optimal: > 1x	0.80x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.72x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.54x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	1.42x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	-1.02x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	-0.33x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.46x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗
Return on Invested Capital (%)	-730.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-755.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	573.8% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-192.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-96.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-64.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-473.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-293.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-88.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-29.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	124.1% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	1.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	0.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-2.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-3.8% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-14.0% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-242.5% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-214.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-389.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-121.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-80.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-66.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-185.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-219.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-91.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-34.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-111.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	1.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	0.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-2.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-4.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	-10.7% Weak Weak Operating profit relative to total assets Optimal: > 10%	—
Return on Common Equity (%) (%)	—	—	—	-243.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1723%)	-121.7% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-911%)	-78.2% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-622%)	—	—	-110.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-838%)	-50.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-434%)	194.6% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1197%)	1.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-89%)	0.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-99%)	2.3% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-85%)	74.4% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+396%)	—	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗
Interest Coverage (x)	—	—	—	—	—	-5176.33x Weak Weak Operating income divided by interest expense Optimal: > 5x	-126.90x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	-4.38x Weak Weak Operating income divided by interest expense Optimal: > 5x	-3.90x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—	—
Net Debt (USD)	$-2.50M	$-2.37M	$-1.10M	$-7.36M	$-12.87M	$-21.41M	$-5.58M	$-5.36M	$-12.69M	$-21.35M	$-3.56M	$-13.84M	$-13.29M	$-12.82M	$-12.68M	$-127.00K	$-4.97M

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗
Revenue per Share (USD)	$0.00	$0.02	$0.02	$0.08	$0.06	—	—	—	—	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-1.23	$-2.90	$-0.55	$-0.67	$-0.75	—	—	—	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-1.12	$-2.88	$-0.47	$-0.60	$-0.62	—	—	—	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$0.08	$0.18	$-0.07	$0.24	$0.61	$1.18	$0.35	$0.78	$0.29	$0.54	$-0.18	$0.06	$0.06	$0.06	$0.06	$0.01	—
Tangible Book Value per Share (USD)	$0.08	$0.18	$-0.07	$0.24	$0.61	$1.18	$0.35	$0.78	$0.29	$0.54	$-0.18	$0.06	$0.06	$0.06	$0.06	$0.01	—
Basic Weighted Avg Shares (shares)	6.67M	2.74M	21.18M	17.72M	16.92M	—	—	—	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗
Working Capital (USD)	$300.00K	$301.00K	$-2.15M	$4.28M	$9.77M	$18.41M	$2.38M	$3.67M	$10.98M	$20.47M	$-3.63M	—	—	—	—	—	—
Total Equity (USD)	$895.00K	$837.00K	$-1.60M	$4.89M	$10.38M	$19.18M	$2.37M	$3.79M	$11.12M	$20.58M	$-3.44M	$13.87M	$13.31M	$13.29M	$12.98M	$3.28M	$14.74M

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗
Sales/Revenue/Turnover (USD)	$0.00	$58.00K	$477.00K	$1.35M	$1.01M	$145.00K	$710.00K	$625.00K	$479.00K	$576.00K	$904.00K	—	—	—	$12.00K	$0.00	—
Depreciation Expense (USD)	$24.00K	$67.00K	$84.00K	$82.00K	$60.00K	$68.00K	$111.00K	$88.00K	$78.00K	$39.00K	$47.00K	—	—	—	—	—	—
Net Income, GAAP (USD)	$-8.23M	$-7.95M	$-11.57M	$-11.91M	$-12.62M	$-15.00M	$-14.71M	$-13.99M	$-12.31M	$-10.31M	$-6.70M	$234.00K	$19.00K	$305.00K	$9.66M	$-11.51M	—
Operating Cash Flow (USD)	$-7.44M	$-7.89M	$-9.97M	$-10.56M	$-10.37M	$-12.36M	$-9.45M	$-11.07M	$-8.67M	$-5.52M	—	—	$27.00K	$-310.00K	$-3.09M	$-4.28M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 17 years · 66 quarters

BioCardia, Inc.

Analytical Summary

17-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Benchmarks unavailable

Compare BCDA with peers